Compensatory Inferior Turbinate Surgery in Septorhinoplasty
CIT
Effect of Concomitant Compensatory Inferior Turbinate Surgery on Functional Outcomes After Septorhinoplasty: A Randomized Controlled Trial
1 other identifier
interventional
80
1 country
1
Brief Summary
Nasal obstruction is a common complaint among patients undergoing septorhinoplasty. In addition to septal deviation, compensatory inferior turbinate hypertrophy may contribute to impaired nasal airflow. For this reason, some surgeons routinely perform inferior turbinate reduction during septorhinoplasty. However, the necessity and functional benefit of this additional procedure remain controversial. The aim of this randomized controlled study is to evaluate whether compensatory inferior turbinate surgery provides additional functional benefit when performed simultaneously with septorhinoplasty. Patients undergoing septorhinoplasty will be randomly assigned to either septorhinoplasty alone or septorhinoplasty combined with inferior turbinate surgery. Functional outcomes will be assessed using both subjective and objective measures. Subjective nasal obstruction will be evaluated using the Nasal Obstruction Symptom Evaluation (NOSE) scale, and objective nasal airflow will be assessed using peak nasal inspiratory flow (PNIF). Patients will be followed for six months after surgery. The results of this study are expected to clarify the role of compensatory inferior turbinate surgery in patients undergoing septorhinoplasty and provide evidence regarding whether routine turbinate intervention is necessary in this patient population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2025
CompletedFirst Submitted
Initial submission to the registry
March 9, 2026
CompletedFirst Posted
Study publicly available on registry
March 18, 2026
CompletedMarch 18, 2026
March 1, 2026
2.7 years
March 9, 2026
March 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Nasal Obstruction Symptom Evaluation (NOSE) score
The Nasal Obstruction Symptom Evaluation (NOSE) scale is a validated patient-reported questionnaire used to assess the severity of nasal obstruction. Scores range from 0 to 100, with higher scores indicating more severe nasal obstruction.
Preoperative baseline and 6 months after surgery
Secondary Outcomes (1)
Change in Peak Nasal Inspiratory Flow (PNIF)
Preoperative baseline and 6 months after surgery
Study Arms (2)
SRP
EXPERIMENTALPatients undergoing standard open functional septorhinoplasty without inferior turbinate intervention.
SRP + CIT Surgery
EXPERIMENTALPatients undergoing septorhinoplasty combined with compensatory inferior turbinate surgery.
Interventions
Standard open functional septorhinoplasty was performed under general anesthesia, including septoplasty, dorsal profile alignment with transverse and lateral osteotomies, tipplasty, bilateral spreader graft placement, and columellar strut grafting. Silicone nasal splints were placed bilaterally and removed after 72 hours.
Inferior turbinate reduction was performed on the non-deviated side using submucosal radiofrequency ablation followed by turbinate lateralization to improve nasal airway patency.
Eligibility Criteria
You may qualify if:
- Patients older than 18 years
- Patients presenting with nasal obstruction and aesthetic concerns requiring septorhinoplasty
- Presence of nasal septal deviation confirmed by anterior rhinoscopy, nasal endoscopy, or computed tomography
- Presence of compensatory inferior turbinate hypertrophy in the contralateral nasal cavity
- Patients willing to participate and able to provide informed consent
You may not qualify if:
- Previous nasal, septal, or turbinate surgery
- Chronic rhinosinusitis with or without nasal polyps
- Bilateral inferior turbinate hypertrophy
- Absence of compensatory inferior turbinate hypertrophy
- Patients requiring additional nasal procedures or grafting techniques beyond the standardized surgical protocol
- Incomplete follow-up
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Etlik City Hospital
Ankara, Ankara, 06010, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zülküf Küçüktağ, M.D.
Saglik Bilimleri Universitesi
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- The investigator responsible for postoperative outcome assessment was blinded to the treatment allocation. Surgical procedures were performed by a single surgeon who was aware of the intervention. Participants were not blinded to the type of procedure performed.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 9, 2026
First Posted
March 18, 2026
Study Start
January 1, 2023
Primary Completion
September 1, 2025
Study Completion
September 1, 2025
Last Updated
March 18, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
No plan to share individual participant data.